With PDUFA Date Coming Up, HGSI Optimistically Outlines Launch Plans For Benlysta
This article was originally published in The Pink Sheet Daily
Executive Summary
Assuming the lupus drug gets FDA approval, HGSI and its 50-50 partner GlaxoSmithKline are ready to launch Benlysta by the end of the first quarter.